Cortactin in tumor invasiveness.

PubWeight™: 1.88‹?› | Rank: Top 3%

🔗 View Article (PMC 2460566)

Published in Cancer Lett on April 10, 2008

Authors

Alissa M Weaver1

Author Affiliations

1: Department of Cancer Biology, Vanderbilt University Medical Center, 448 PRB, VUMC, Nashville, TN 37232-6840, USA. Alissa.weaver@vanderbilt.edu

Articles citing this

The 'ins' and 'outs' of podosomes and invadopodia: characteristics, formation and function. Nat Rev Mol Cell Biol (2011) 4.24

RhoA and RhoC have distinct roles in migration and invasion by acting through different targets. J Cell Biol (2011) 2.59

Functional proteomics identifies targets of phosphorylation by B-Raf signaling in melanoma. Mol Cell (2009) 2.50

Cortactin branches out: roles in regulating protrusive actin dynamics. Cell Motil Cytoskeleton (2008) 2.26

The cofilin activity cycle in lamellipodia and invadopodia. J Cell Biochem (2009) 1.99

Specific tyrosine phosphorylation sites on cortactin regulate Nck1-dependent actin polymerization in invadopodia. J Cell Sci (2010) 1.53

Cortactin phosphorylation regulates cell invasion through a pH-dependent pathway. J Cell Biol (2011) 1.38

Cortactin in cell migration and cancer at a glance. J Cell Sci (2012) 1.34

Protein kinase D controls actin polymerization and cell motility through phosphorylation of cortactin. J Biol Chem (2010) 1.32

Isolation of circulating epithelial and tumor progenitor cells with an invasive phenotype from breast cancer patients. Int J Cancer (2010) 1.31

Cell-specific interaction of retinoic acid receptors with target genes in mouse embryonic fibroblasts and embryonic stem cells. Mol Cell Biol (2010) 1.30

EphA2 mutation in lung squamous cell carcinoma promotes increased cell survival, cell invasion, focal adhesions, and mammalian target of rapamycin activation. J Biol Chem (2010) 1.27

Ephexin4 and EphA2 mediate cell migration through a RhoG-dependent mechanism. J Cell Biol (2010) 1.24

Multiparametric classification links tumor microenvironments with tumor cell phenotype. PLoS Biol (2014) 1.22

Genomic characterization of esophageal squamous cell carcinoma from a high-risk population in China. Cancer Res (2009) 1.20

A cell-based high-content screening assay reveals activators and inhibitors of cancer cell invasion. Sci Signal (2011) 1.20

Regulation of invasive behavior by vascular endothelial growth factor is HEF1-dependent. Oncogene (2010) 1.19

Cortactin phosphorylated by ERK1/2 localizes to sites of dynamic actin regulation and is required for carcinoma lamellipodia persistence. PLoS One (2010) 1.17

Aggressiveness of HNSCC tumors depends on expression levels of cortactin, a gene in the 11q13 amplicon. Oncogene (2008) 1.16

Supervillin reorganizes the actin cytoskeleton and increases invadopodial efficiency. Mol Biol Cell (2008) 1.15

Cortactin controls cell motility and lamellipodial dynamics by regulating ECM secretion. Curr Biol (2011) 1.14

Invading one step at a time: the role of invadopodia in tumor metastasis. Oncogene (2013) 1.13

Epithelial and mesenchymal phenotypic switchings modulate cell motility in metastasis. Front Biosci (Landmark Ed) (2011) 1.12

Saracatinib Impairs Head and Neck Squamous Cell Carcinoma Invasion by Disrupting Invadopodia Function. J Cancer Sci Ther (2009) 1.11

Rab40b regulates trafficking of MMP2 and MMP9 during invadopodia formation and invasion of breast cancer cells. J Cell Sci (2013) 1.04

Aberrant overexpression of the Rgl2 Ral small GTPase-specific guanine nucleotide exchange factor promotes pancreatic cancer growth through Ral-dependent and Ral-independent mechanisms. J Biol Chem (2010) 0.96

Nck1 and Grb2 localization patterns can distinguish invadopodia from podosomes. Eur J Cell Biol (2010) 0.95

Amplification of MPZL1/PZR promotes tumor cell migration through Src-mediated phosphorylation of cortactin in hepatocellular carcinoma. Cell Res (2013) 0.92

Cortactin is implicated in murine zygotic development. Exp Cell Res (2009) 0.91

Hematopoietic lineage cell-specific protein 1 functions in concert with the Wiskott-Aldrich syndrome protein to promote podosome array organization and chemotaxis in dendritic cells. J Immunol (2011) 0.91

The homolog of the five SH3-domain protein (HOFI/SH3PXD2B) regulates lamellipodia formation and cell spreading. PLoS One (2011) 0.91

Src-mediated phosphorylation of mammalian Abp1 (DBNL) regulates podosome rosette formation in transformed fibroblasts. J Cell Sci (2012) 0.90

The Golgi in cell migration: regulation by signal transduction and its implications for cancer cell metastasis. ScientificWorldJournal (2012) 0.90

Distinct phosphorylation requirements regulate cortactin activation by TirEPEC and its binding to N-WASP. Cell Commun Signal (2009) 0.88

Cortactin colocalizes with filopodial actin and accumulates at IgCAM adhesion sites in Aplysia growth cones. J Neurosci Res (2009) 0.88

FAK competes for Src to promote migration against invasion in melanoma cells. Cell Death Dis (2014) 0.87

A Golgi-based KDELR-dependent signalling pathway controls extracellular matrix degradation. Oncotarget (2015) 0.87

Cytoskeleton alterations in melanoma: aberrant expression of cortactin, an actin-binding adapter protein, correlates with melanocytic tumor progression. Mod Pathol (2009) 0.87

Dynamics between actin and the VE-cadherin/catenin complex: novel aspects of the ARP2/3 complex in regulation of endothelial junctions. Cell Adh Migr (2014) 0.86

SYK allelic loss and the role of Syk-regulated genes in breast cancer survival. PLoS One (2014) 0.86

HER2 carboxyl-terminal fragments regulate cell migration and cortactin phosphorylation. J Biol Chem (2009) 0.85

Cortactin modulates RhoA activation and expression of Cip/Kip cyclin-dependent kinase inhibitors to promote cell cycle progression in 11q13-amplified head and neck squamous cell carcinoma cells. Mol Cell Biol (2010) 0.85

Gene expression of human lung cancer cell line CL1-5 in response to a direct current electric field. PLoS One (2011) 0.85

Cortactin controls surface expression of the voltage-gated potassium channel K(V)10.1. J Biol Chem (2012) 0.84

Cortactin is a substrate of activated Cdc42-associated kinase 1 (ACK1) during ligand-induced epidermal growth factor receptor downregulation. PLoS One (2012) 0.84

Identification of metastasis-suppressive microRNAs in primary melanoma. J Natl Cancer Inst (2015) 0.83

An eQTL-based method identifies CTTN and ZMAT3 as pemetrexed susceptibility markers. Hum Mol Genet (2011) 0.83

Hax-1 is required for Rac1-Cortactin interaction and ovarian carcinoma cell migration. Genes Cancer (2014) 0.83

Sirtuin1 Maintains Actin Cytoskeleton by Deacetylation of Cortactin in Injured Podocytes. J Am Soc Nephrol (2014) 0.82

Cortactin tyrosine phosphorylation promotes its deacetylation and inhibits cell spreading. PLoS One (2012) 0.81

Cortactin is involved in the entry of Coxiella burnetii into non-phagocytic cells. PLoS One (2012) 0.81

NEDD9 regulates actin dynamics through cortactin deacetylation in an AURKA/HDAC6-dependent manner. Mol Cancer Res (2014) 0.81

5'-Inositol phosphatase SHIP2 recruits Mena to stabilize invadopodia for cancer cell invasion. J Cell Biol (2016) 0.78

Regulation of invadopodia by mechanical signaling. Exp Cell Res (2015) 0.78

A proteomic profiling of laser-microdissected lung adenocarcinoma cells of early lepidic-types. Clin Transl Med (2015) 0.78

Further insights into cortactin conformational regulation. Bioarchitecture (2011) 0.78

Releasing the brakes while hanging on: Cortactin effects on actin-driven motility. Bioarchitecture (2012) 0.78

pTyr421 cortactin is overexpressed in colon cancer and is dephosphorylated by curcumin: involvement of non-receptor type 1 protein tyrosine phosphatase (PTPN1). PLoS One (2014) 0.78

Cofilin-1 and Other ADF/Cofilin Superfamily Members in Human Malignant Cells. Int J Mol Sci (2016) 0.76

TEM7 (PLXDC1), a key prognostic predictor for resectable gastric cancer, promotes cancer cell migration and invasion. Am J Cancer Res (2015) 0.76

Cortactin, another player in the Lyn signaling pathway, is over-expressed and alternatively spliced in leukemic cells from patients with B-cell chronic lymphocytic leukemia. Haematologica (2014) 0.76

Novel role of cortactin in G protein-coupled receptor agonist-induced nuclear export and degradation of p21Cip1. Sci Rep (2016) 0.75

Src tyrosyl phosphorylates cortactin in response to prolactin. Biochem Biophys Res Commun (2015) 0.75

Constrained inference of protein interaction networks for invadopodium formation in cancer. IET Syst Biol (2016) 0.75

Macrophages promote matrix protrusive and invasive function of breast cancer cells via MIP-1β dependent upregulation of MYO3A gene in breast cancer cells. Oncoimmunology (2016) 0.75

Asporin enhances colorectal cancer metastasis through activating the EGFR/src/cortactin signaling pathway. Oncotarget (2016) 0.75

Clinical Implications of FADD Gene Amplification and Protein Overexpression in Taiwanese Oral Cavity Squamous Cell Carcinomas. PLoS One (2016) 0.75

Interaction Between Ezrin and Cortactin in Promoting Epithelial to Mesenchymal Transition in Breast Cancer Cells. Med Sci Monit (2017) 0.75

Cortactin promotes colorectal cancer cell proliferation by activating the EGFR-MAPK pathway. Oncotarget (2016) 0.75

Macrophage-dependent tumor cell transendothelial migration is mediated by Notch1/Mena(INV)-initiated invadopodium formation. Sci Rep (2016) 0.75

Articles cited by this

Head and neck cancer. N Engl J Med (2001) 7.32

The ARP2/3 complex: an actin nucleator comes of age. Nat Rev Mol Cell Biol (2006) 6.04

Coupling between clathrin-coated-pit invagination, cortactin recruitment, and membrane scission observed in live cells. Cell (2005) 4.71

Regulation of actin filament network formation through ARP2/3 complex: activation by a diverse array of proteins. Annu Rev Biochem (2001) 4.54

Activation of Arp2/3 complex-mediated actin polymerization by cortactin. Nat Cell Biol (2001) 4.38

Regulation of the actin cytoskeleton in cancer cell migration and invasion. Biochim Biophys Acta (2006) 4.27

The matrix corroded: podosomes and invadopodia in extracellular matrix degradation. Trends Cell Biol (2007) 4.23

Cortactin promotes and stabilizes Arp2/3-induced actin filament network formation. Curr Biol (2001) 4.16

HDAC6 modulates cell motility by altering the acetylation level of cortactin. Mol Cell (2007) 3.99

Dynamic interactions of cortactin and membrane type 1 matrix metalloproteinase at invadopodia: defining the stages of invadopodia formation and function. Cancer Res (2006) 3.83

Identification and characterization of a novel cytoskeleton-associated pp60src substrate. Mol Cell Biol (1991) 3.83

Influence of the C terminus of Wiskott-Aldrich syndrome protein (WASp) and the Arp2/3 complex on actin polymerization. Biochemistry (1999) 3.77

Cortactin, an 80/85-kilodalton pp60src substrate, is a filamentous actin-binding protein enriched in the cell cortex. J Cell Biol (1993) 3.56

Interaction of cortactin and N-WASp with Arp2/3 complex. Curr Biol (2002) 3.34

Regulated interactions between dynamin and the actin-binding protein cortactin modulate cell shape. J Cell Biol (2000) 3.30

Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia. Cancer Res (2007) 3.30

c-Abl is activated by growth factors and Src family kinases and has a role in the cellular response to PDGF. Genes Dev (1999) 3.09

Invadopodia: specialized cell structures for cancer invasion. Clin Exp Metastasis (2006) 3.05

Cortactin localization to sites of actin assembly in lamellipodia requires interactions with F-actin and the Arp2/3 complex. J Cell Biol (2000) 2.94

An invasion-related complex of cortactin, paxillin and PKCmu associates with invadopodia at sites of extracellular matrix degradation. Oncogene (1999) 2.86

Cortactin promotes cell motility by enhancing lamellipodial persistence. Curr Biol (2005) 2.78

Cortactin: coupling membrane dynamics to cortical actin assembly. Oncogene (2001) 2.77

Profiling early head and neck cancer. Nat Rev Cancer (2005) 2.62

Actin and Arf1-dependent recruitment of a cortactin-dynamin complex to the Golgi regulates post-Golgi transport. Nat Cell Biol (2005) 2.50

Arp2/3 ATP hydrolysis-catalysed branch dissociation is critical for endocytic force generation. Nat Cell Biol (2006) 2.48

Pulmonary endothelial cell barrier enhancement by sphingosine 1-phosphate: roles for cortactin and myosin light chain kinase. J Biol Chem (2004) 2.44

The role of tyrosine phosphorylation of cortactin in the locomotion of endothelial cells. J Biol Chem (1998) 2.39

Erk/Src phosphorylation of cortactin acts as a switch on-switch off mechanism that controls its ability to activate N-WASP. Mol Cell Biol (2004) 2.36

Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas. Oncogene (1992) 2.22

Src phosphorylation of cortactin enhances actin assembly. Proc Natl Acad Sci U S A (2007) 2.16

Cyclin D1, EMS1 and 11q13 amplification in breast cancer. Breast Cancer Res Treat (2003) 2.14

Multiple regulatory inputs converge on cortactin to control invadopodia biogenesis and extracellular matrix degradation. J Cell Sci (2008) 2.06

A Cortactin-CD2-associated protein (CD2AP) complex provides a novel link between epidermal growth factor receptor endocytosis and the actin cytoskeleton. J Biol Chem (2003) 1.99

Essential role of neural Wiskott-Aldrich syndrome protein in podosome formation and degradation of extracellular matrix in src-transformed fibroblasts. Cancer Res (2002) 1.96

Co-localization of cortactin and phosphotyrosine identifies active invadopodia in human breast cancer cells. Exp Cell Res (2006) 1.96

Cortactin is a component of clathrin-coated pits and participates in receptor-mediated endocytosis. Mol Cell Biol (2003) 1.92

Cortactin tyrosine phosphorylation requires Rac1 activity and association with the cortical actin cytoskeleton. Mol Biol Cell (2003) 1.90

Specificity, selection and significance of gene amplifications in cancer. Semin Cancer Biol (2006) 1.86

Cortactin potentiates bone metastasis of breast cancer cells. Cancer Res (2001) 1.85

Cortactin is necessary for E-cadherin-mediated contact formation and actin reorganization. J Cell Biol (2004) 1.74

Cortactin interacts with WIP in regulating Arp2/3 activation and membrane protrusion. Curr Biol (2003) 1.72

Expression of AMAP1, an ArfGAP, provides novel targets to inhibit breast cancer invasive activities. EMBO J (2005) 1.69

A critical role for cortactin phosphorylation by Abl-family kinases in PDGF-induced dorsal-wave formation. Curr Biol (2007) 1.69

Identification of a novel cortactin SH3 domain-binding protein and its localization to growth cones of cultured neurons. Mol Cell Biol (1998) 1.68

The involvement of the chromosome 11q13 region in human malignancies: cyclin D1 and EMS1 are two new candidate oncogenes--a review. Gene (1995) 1.61

Cortactin regulates cell migration through activation of N-WASP. J Cell Sci (2004) 1.61

A Hip1R-cortactin complex negatively regulates actin assembly associated with endocytosis. EMBO J (2007) 1.57

Cortactin underpins CD44-promoted invasion and adhesion of breast cancer cells to bone marrow endothelial cells. Oncogene (2006) 1.56

The product of the EMS1 gene, amplified and overexpressed in human carcinomas, is homologous to a v-src substrate and is located in cell-substratum contact sites. Mol Cell Biol (1993) 1.53

A new role for cortactin in invadopodia: regulation of protease secretion. Eur J Cell Biol (2008) 1.52

Cortactin has an essential and specific role in osteoclast actin assembly. Mol Biol Cell (2006) 1.52

Mechanism of filament nucleation and branch stability revealed by the structure of the Arp2/3 complex at actin branch junctions. PLoS Biol (2005) 1.52

Two distinct phosphorylation pathways have additive effects on Abl family kinase activation. Mol Cell Biol (2003) 1.50

p80/85 cortactin associates with the Src SH2 domain and colocalizes with v-Src in transformed cells. J Biol Chem (1995) 1.48

EMS1 gene amplification correlates with poor prognosis in squamous cell carcinomas of the head and neck. Clin Cancer Res (2000) 1.44

Differential regulation of cortactin and N-WASP-mediated actin polymerization by missing in metastasis (MIM) protein. Oncogene (2005) 1.42

Overexpression of EMS1/cortactin in NIH3T3 fibroblasts causes increased cell motility and invasion in vitro. Oncogene (1998) 1.41

Analysis of the mechanisms of Salmonella-induced actin assembly during invasion of host cells and intracellular replication. Cell Microbiol (2004) 1.40

Signaling pathways and structural domains required for phosphorylation of EMS1/cortactin. Cancer Res (1999) 1.39

Amplicon mapping and expression profiling identify the Fas-associated death domain gene as a new driver in the 11q13.3 amplicon in laryngeal/pharyngeal cancer. Clin Cancer Res (2007) 1.37

Overexpression of cortactin is involved in motility and metastasis of hepatocellular carcinoma. J Hepatol (2004) 1.37

A neural Wiskott-Aldrich Syndrome protein-mediated pathway for localized activation of actin polymerization that is regulated by cortactin. J Biol Chem (2004) 1.37

Cortactin phosphorylation as a switch for actin cytoskeletal network and cell dynamics control. FEBS Lett (2005) 1.37

Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression. Cancer (1997) 1.34

Fgd1, the Cdc42 GEF responsible for Faciogenital Dysplasia, directly interacts with cortactin and mAbp1 to modulate cell shape. Hum Mol Genet (2003) 1.33

Cortactin overexpression regulates actin-related protein 2/3 complex activity, motility, and invasion in carcinomas with chromosome 11q13 amplification. Cancer Res (2006) 1.31

A noncanonical SH3 domain binding motif links BK channels to the actin cytoskeleton via the SH3 adapter cortactin. FASEB J (2006) 1.31

Proteolysis of cortactin by calpain regulates membrane protrusion during cell migration. Mol Biol Cell (2005) 1.30

Amplification and overexpression of CTTN (EMS1) contribute to the metastasis of esophageal squamous cell carcinoma by promoting cell migration and anoikis resistance. Cancer Res (2006) 1.29

Chromosomal abnormalities involving 11q13 are associated with poor prognosis in patients with squamous cell carcinoma of the head and neck. Cancer (1995) 1.28

Cortactin associates with the cell-cell junction protein ZO-1 in both Drosophila and mouse. J Biol Chem (1998) 1.28

Receptor-mediated endocytosis involves tyrosine phosphorylation of cortactin. J Biol Chem (2007) 1.26

Dissecting the functional domain requirements of cortactin in invadopodia formation. Eur J Cell Biol (2007) 1.23

Regulation of cortactin/dynamin interaction by actin polymerization during the fission of clathrin-coated pits. J Cell Sci (2005) 1.23

Fer-mediated cortactin phosphorylation is associated with efficient fibroblast migration and is dependent on reactive oxygen species generation during integrin-mediated cell adhesion. Mol Cell Biol (2007) 1.22

Cortactin affects cell migration by regulating intercellular adhesion and cell spreading. Exp Cell Res (2006) 1.21

Phosphorylation of cortactin by p21-activated kinase. Arch Biochem Biophys (2006) 1.21

Genetic imbalances with impact on survival in head and neck cancer patients. Am J Pathol (2000) 1.20

Tyrosine phosphorylation of Kv1.2 modulates its interaction with the actin-binding protein cortactin. J Biol Chem (2002) 1.18

Chromosome 11q13 amplification in head and neck squamous cell carcinoma. Association with poor prognosis. Arch Otolaryngol Head Neck Surg (1995) 1.15

Aberrant expression of cortactin in head and neck squamous cell carcinoma cells is associated with enhanced cell proliferation and resistance to the epidermal growth factor receptor inhibitor gefitinib. Cancer Res (2007) 1.14

Cortactin overexpression inhibits ligand-induced down-regulation of the epidermal growth factor receptor. Cancer Res (2005) 1.11

Isolation and characterization of cortactin isoforms and a novel cortactin-binding protein, CBP90. Genes Cells (1998) 1.11

Cortactin regulates podosome formation: roles of the protein interaction domains. Exp Cell Res (2006) 1.10

Cortactin associates with N-cadherin adhesions and mediates intercellular adhesion strengthening in fibroblasts. J Cell Sci (2004) 1.09

Cortactin phosphorylation sites mapped by mass spectrometry. J Cell Sci (2006) 1.08

EMS1 amplification can occur independently of CCND1 or INT-2 amplification at 11q13 and may identify different phenotypes in primary breast cancer. Oncogene (1997) 1.08

Amplification and overexpression of the EMS 1 oncogene, a possible prognostic marker, in human hepatocellular carcinoma. J Mol Diagn (2003) 1.05

EMS1 gene expression in primary breast cancer: relationship to cyclin D1 and oestrogen receptor expression and patient survival. Oncogene (1998) 1.05

Phosphorylation of N-cadherin-associated cortactin by Fer kinase regulates N-cadherin mobility and intercellular adhesion strength. Mol Biol Cell (2005) 1.04

Cortactin modulates cell migration and ring canal morphogenesis during Drosophila oogenesis. Mech Dev (2004) 1.01

Markers for assessment of nodal metastasis in laryngeal carcinoma. Arch Otolaryngol Head Neck Surg (1997) 0.99

Chromosome 11Q13 amplification in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg (1993) 0.95

Recurrent coamplification of cytoskeleton-associated genes EMS1 and SHANK2 with CCND1 in oral squamous cell carcinoma. Genes Chromosomes Cancer (2006) 0.94

Overexpression of cyclin D1 and cortactin is primarily independent of gene amplification in salivary gland adenoid cystic carcinoma. Oral Oncol (2006) 0.93

Filamentous actin binding ability of cortactin isoforms is responsible for their cell-cell junctional localization in epithelial cells. Arch Biochem Biophys (2004) 0.89

BPGAP1 interacts with cortactin and facilitates its translocation to cell periphery for enhanced cell migration. Mol Biol Cell (2004) 0.87

Direct interaction between caldesmon and cortactin. Arch Biochem Biophys (2006) 0.85

Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice. BMC Cancer (2006) 0.83